FDA clears Servier and Pfizer for clinical development of UCART19 for acute lymphoblastic leukemia

Servier and Pfizer Inc. have received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) to proceed with the clinical development ... Read More